Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02939274
Recruitment Status : Unknown
Verified July 2018 by Rogers Sciences Inc..
Recruitment status was:  Recruiting
First Posted : October 20, 2016
Last Update Posted : July 20, 2018
Sponsor:
Information provided by (Responsible Party):
Rogers Sciences Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : December 2019